V1/2act (mV) | kact | V1/2inact (mV) | kinact | |
---|---|---|---|---|
Control | −8.45 ± 0.21 | 4.73 ± 0.19 | −30.55 ± 0.17 | 4.72 ± 0.15 |
(n = 13) | (n = 10) | |||
CCL2 (10 nm) | −13.72 ± 0.22* | 3.5 ± 0.19 | −37.02 ± 0.16** | 3.66 ± 0.14 |
(n = 4) | (n = 7) | |||
CCL2 (100 nm) | −18.74 ± 0.31*** | 4.47 ± 0.29 | −40.61 ± 0.09*** | 4.81 ± 0.08 |
(n = 11) | (n = 10) | |||
CCL2 (100 nm) +INCB3344 (100 nm) | −7.47 ± 0.26## | 5.01 ± 0.23 | −31.02 ± 0.16### | 3.59 ± 0.14 |
(n = 7) | (n = 5) | |||
CCL2 (100 nm) +PTX (250 ng/ml) | −7.04 ± 0.22## | 4.14 ± 0.20 | ND | ND |
(n = 9) | ||||
CCL2 (100 nm) +gallein (20 μm) | −6.09 ± 0.22### | 4.10 ± 0.17 | ND | ND |
(n = 6) |
V1/2act and V1/2inact are the membrane potentials for half-maximal channel activation or inactivation, respectively. kact and kinact represent the slope factors for activation and inactivation. The numbers in parentheses reflect numbers of recorded neurons. ND, Not determined.
↵**p < 0.01 and ***p < 0.001 indicate statistically significant differences with control group. ##p < 0.01 and ###p < 0.001 compared with CCL2 alone.